QMS MEDICAL ALLIED SERVICES
|
QMS MEDICAL ALLIED SERVICES Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 5.04 | 3.57 | 28.40 | 29.02 | 21.12 |
| CEPS(Rs) | 6.97 | 4.17 | 7.87 | 7.74 | 4.46 |
| DPS(Rs) | 0.50 | 0.50 | - | - | - |
| Book NAV/Share(Rs) | 43.99 | 39.44 | 82.48 | 54.02 | 31.26 |
| Tax Rate(%) | 26.43 | 26.73 | 26.08 | 26.76 | 27.10 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 15.02 | 10.89 | 11.37 | 13.93 | 13.20 |
| EBIT Margin(%) | 12.58 | 10.57 | 11.55 | 13.37 | 12.76 |
| Pre Tax Margin(%) | 10.02 | 8.37 | 9.88 | 12.21 | 11.99 |
| PAT Margin (%) | 7.37 | 6.13 | 7.30 | 8.95 | 8.74 |
| Cash Profit Margin (%) | 10.19 | 7.16 | 8.10 | 9.55 | 9.23 |
| Performance Ratios | |||||
| ROA(%) | 7.05 | 6.27 | 14.70 | 23.27 | 24.76 |
| ROE(%) | 12.09 | 12.58 | 41.62 | 73.44 | 102.03 |
| ROCE(%) | 14.70 | 13.83 | 32.83 | 53.55 | 64.85 |
| Asset Turnover(x) | 0.96 | 1.02 | 2.01 | 2.60 | 2.83 |
| Sales/Fixed Asset(x) | 4.18 | 5.44 | 13.80 | 16.34 | 38.45 |
| Working Capital/Sales(x) | 2.36 | 2.50 | 5.89 | 11.25 | 12.16 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.24 | 0.18 | 0.07 | 0.06 | 0.03 |
| Receivable days | 120.20 | 142.24 | 81.10 | 51.14 | 48.25 |
| Inventory Days | 100.89 | 95.04 | 55.58 | 53.84 | 61.84 |
| Payable days | 89.36 | 84.96 | 58.07 | 59.68 | 69.29 |
| Valuation Parameters | |||||
| PER(x) | 23.21 | 36.58 | - | - | - |
| PCE(x) | 16.79 | 31.31 | - | - | - |
| Price/Book(x) | 2.66 | 3.31 | - | - | - |
| Yield(%) | 0.43 | 0.38 | - | - | - |
| EV/Net Sales(x) | 1.99 | 2.46 | 0.23 | 0.18 | 0.19 |
| EV/Core EBITDA(x) | 12.93 | 21.26 | 1.86 | 1.29 | 1.45 |
| EV/EBIT(x) | 15.83 | 23.33 | 1.99 | 1.35 | 1.50 |
| EV/CE(x) | 2.15 | 2.67 | 0.40 | 0.36 | 0.42 |
| M Cap / Sales | 1.71 | 2.24 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 17.38 | -28.89 | 19.90 | 67.77 | 40.17 |
| Core EBITDA Growth(%) | 55.83 | -33.18 | 5.91 | 76.92 | 106.61 |
| EBIT Growth(%) | 39.74 | -34.93 | 3.55 | 75.82 | 100.39 |
| PAT Growth(%) | 41.14 | -40.32 | -2.11 | 71.72 | 109.43 |
| EPS Growth(%) | 41.14 | -87.42 | -2.11 | 37.37 | -99.30 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.44 | 0.36 | 1.03 | 0.96 | 1.23 |
| Current Ratio(x) | 1.93 | 1.90 | 1.48 | 1.28 | 1.25 |
| Quick Ratio(x) | 1.26 | 1.25 | 1.01 | 0.76 | 0.60 |
| Interest Cover(x) | 4.91 | 4.81 | 6.93 | 11.58 | 16.60 |
| Total Debt/Mcap(x) | 0.17 | 0.11 | - | - | - |
Compare Financial Ratios of peers of QMS MEDICAL ALLIED SERVICES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| QMS MEDICAL ALLIED SERVICES | ₹184.4 Cr | 7.2% | -9.2% | -28.4% | Stock Analytics | |
| ADANI ENTERPRISES | ₹257,302.0 Cr | 3.9% | -3.5% | -32.1% | Stock Analytics | |
| REDINGTON | ₹19,176.9 Cr | 7.4% | 7.3% | 16.6% | Stock Analytics | |
| MMTC | ₹7,894.5 Cr | 4.8% | -22.3% | -31.5% | Stock Analytics | |
| HONASA CONSUMER | ₹7,061.4 Cr | -0.2% | -1% | -45.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹5,419.3 Cr | 2.2% | -19% | 21.3% | Stock Analytics | |
QMS MEDICAL ALLIED SERVICES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| QMS MEDICAL ALLIED SERVICES | 7.2% |
-9.2% |
-28.4% |
| SENSEX | 1.4% |
-5.3% |
0.3% |
You may also like the below Video Courses
